← Open Payments lookup

VICTORIA RAMOS: Open Payments

NPI 1841704806 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$994 in 43 payments from 10 companies in 2025. Trend: 2023 $384 · 2024 $520 · 2025 $994

Food & beverage: $962Education: $32
CompanyPaymentsAmount
ABBVIE INC.20$429
Madrigal Pharmaceuticals7$240
Takeda Pharmaceuticals U.S.A., Inc.4$88
Janssen Biotech, Inc.4$75
PFIZER INC.2$46
Novo Nordisk Inc2$41
Braintree Laboratories, Inc.1$20
IRONWOOD PHARMACEUTICALS, INC1$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
Gilead Sciences, Inc.1$15

Products named: REZDIFFRA, SKYRIZI, LINZESS, TREMFYA, RINVOQ, CREON, Wegovy, ENTYVIO.

Industry payments across TX — which companies pay providers there.